QA: NEOGEN CORP in us_medicinal_products/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000711377_2023_NEOGEN_CORP.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000711377, NEOGEN CORP

  xvar xval
0 LiabilitiesNoncurrent 10,700,000
1 LiabilitiesCurrent 94,855,000
2 remainder_Liabilities 0
3 AssetsCurrent 626,798,000
4 AssetsNoncurrent 5,340,000
5 PropertyPlantAndEquipmentNet 110,584,000
6 Goodwill 234,810,000
7 remainder_Assets 15,397,000
8 GeneralAndAdministrativeExpense 451,492,000
9 ResearchAndDevelopmentExpense 17,049,000
10 remainder_Expenses 11,900,000
11 remainder_Revenues 527,159,000
12 remainder_NetIncome 1,589,000
13 remainder_ComprehensiveNetIncome -16,394,000
  yvar yval
0 Liabilities 105,555,000
1 Assets 992,929,000
2 Expenses 480,441,000
3 Revenues 527,159,000
4 StockholdersEquity 887,374,000
5 NetIncome 48,307,000
6 ComprehensiveNetIncome 40,110,000
7 BaseVar 1,062,033,500
8 EconomicCapitalRatio 1.45

Edgar->Model Mapping

Feature Distribution

Change over Time